Ribonuclease inhibitors from mouse ascites cells

Area of Science:

• Biochemistry
• Molecular Biology
• Enzymology

Background:

• Ribonucleases (RNases) are enzymes crucial for RNA metabolism and regulation.
• The presence and function of endogenous RNase inhibitors in mammalian cells are not fully understood.
• Mouse ascites tumor cells are a model system for studying cellular components.

Purpose of the Study:

• To identify and characterize ribonuclease inhibitors in mouse ascites ribosomes and supernatant.
• To determine the substrate specificity and inhibitory mechanism of these RNase inhibitors.
• To investigate whether the inhibitors found in different cellular fractions are identical.

Main Methods:

• Isolation of ribosomes and post-ribosomal supernatant from mouse ascites cells.
• Assay of ribonuclease inhibitory activity against various purified ribonucleases (pancreatic RNases A and B, ascites endonucleases, RNases T1 and N1).
• Determination of sedimentation coefficients to assess inhibitor identity.

Main Results:

• Ribonuclease inhibitors were detected both attached to ribosomes and in the post-ribosomal supernatant.
• The inhibitors effectively neutralized pancreatic RNases A and B, and two ascites-derived endonucleases.
• Inhibitory activity was not observed against RNases T1 or N1.
• Both inhibitors exhibited identical sedimentation coefficients, strongly suggesting they are the same molecular entity.
• Evidence indicated a direct interaction between the inhibitor and the ribonuclease enzyme.

Conclusions:

• Mouse ascites cells possess potent ribonuclease inhibitors associated with both ribosomes and the soluble fraction.
• These inhibitors display specific activity against certain RNases, implying a regulatory role in RNA processing or stability.
• The identical properties of the inhibitors from different fractions support their molecular identity and direct enzyme interaction mechanism.